FindTrial
Sign In

Intranasal dexmedetomidine to the effects of blood pressure and heart rate to intubation

EFFICACY OF DIFFERENT DOSES OF INTRANASAL DEXMEDETOMIDINE ON HEMODYNAMIC RESPONSE TO INTUBATION - A PROSPECTIVE DOUBLE BLINDED CONTROLLED TRIAL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/05/033305
Enrollment
102
Registered
2021-05-03
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I10- Essential (primary) hypertension Health Condition 2: E039- Hypothyroidism, unspecified Health Condition 3: O- Medical and Surgical Health Condition 4: E119- Type 2 diabetes mellitus without complications

Interventions

Intervention1: INTRANASAL DEXMEDETOMIDINE: INTRANASAL DEXMEDETOMIDINE 1 mcg/kg ,40 min before intubation Control Intervention1: INTRANASAL DEXMEDETOMIDINE: INTRANASAL DEXMEDETOMIDINE 0.75mcg/kg , 40 m

Sponsors

SUJATHA
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: age - 18 to 60 yrs elective surgery under general anesthesia

Exclusion criteria

Exclusion criteria: 1.patient refusal 2.allergy to dexmedetomidine 3.significant respiratory and cardiac disease 4.predicted difficult airway patient with nasal polyps,ulcers

Design outcomes

Primary

MeasureTime frame
TO COMPARE THE SYSTOLIC BLOOD PRESSURE, DIASTOLIC BLOOD PRESSURE ,MEAN ARTERIAL PRESSURETimepoint: 0 min,30 min,preinduction,preintubation,postinduction for over 10 min—

Secondary

MeasureTime frame
TO COMPARE THE SEDATION SCORE AND OTHER ADVERSE EVENTSTimepoint: 3 HRS—

Countries

India

Contacts

Public ContactSujatha

SRI RAMACHANDRA INSTITUTE OF HIGHER EDUCATION AND RESEARCH

vakamudi@gmail.com9840022626

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026